1039MO CheckMate 204: 3-year outcomes of treatment with combination nivolumab (NIVO) plus ipilimumab (IPI) for patients (pts) with active melanoma brain metastases (MBM)
| Autor: | Tawbi, H.A., Forsyth, P.A., Hodi, F.S., Algazi, A., Hamid, O., Lao, C.D., Moschos, S.J., Atkins, M.B., Lewis, K., Postow, M.A., Thomas, R.P., Khushalani, N.I., Pavlick, A.C., Ernstoff, M.S., Reardon, D.A., Chung, C., Lee, C-W., Bas, T., Askelson, M., Margolin, K.A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S871-S872 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|